XML 67 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Balance Sheet Components (Tables)
12 Months Ended
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

 

 

December 31,

 

(In thousands)

 

2024

 

 

2023

 

Raw materials

 

$

11,113

 

 

$

11,257

 

Work-in-process

 

 

20,529

 

 

 

15,670

 

Finished goods

 

 

2,083

 

 

 

13,810

 

Total inventory

 

$

33,725

 

 

$

40,737

 

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

 

 

 

December 31,

 

(In thousands)

 

2024

 

 

2023

 

Accrued contract manufacturing expenses

 

$

1,071

 

 

$

1,966

 

Accrued clinical and research expenses

 

 

611

 

 

 

776

 

Accrued professional services

 

 

8,682

 

 

 

8,876

 

Current portion of lease liabilities

 

 

1,572

 

 

 

1,207

 

Royalty obligation payable

 

 

2,951

 

 

 

1,928

 

Current portion of deferred royalty obligation

 

 

6,438

 

 

 

 

Accrued license fees and royalties

 

 

1,727

 

 

 

1,575

 

Other

 

 

6,947

 

 

 

3,370

 

Total other accrued liabilities

 

$

29,999

 

 

$

19,698

 

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:

 

 

 

December 31,

 

(In thousands)

 

2024

 

 

2023

 

Long-term portion of deferred royalty obligation

 

$

63,096

 

 

$

69,876

 

Long-term portion of lease liabilities

 

 

1,179

 

 

 

1,635

 

Contingent value rights liability

 

 

 

 

 

359

 

Total other long-term liabilities

 

$

64,275

 

 

$

71,870